693 PD2M Panel Discussion (Invited Talks)


Description:
This session will feature invited talks from the leaders in QbD filing arena from both the pharmaceutical industry and regulatory agencies elaborating on the current status, practices and perspectives. Emphasis will be on panel discussion with open Q&A to share recent experiences with QbD filing, evolution of regulatory environment along with the challenges and opportunities to do so.

Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum


Co-chairs:

Jean Tom
Chemical Development, Bristol Myers Squibb, New Brunswick, NJ

Moiz Diwan
Process Research and Development, AbbVie, North Chicago, IL

Andreas Bommarius
School of Chemical & Biomolecular Engineering, Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA
Abstract Submissions Closed